AB
CLVS
Amalgamated Bank’s Clovis Oncology, Inc. CLVS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-18,424
| Closed | -$37K | – | 3305 |
|
|
2022
Q1 | $37K | Sell |
18,424
-1,419
| -7% | -$2.85K | ﹤0.01% | 2611 |
|
|
2021
Q4 | $54K | Sell |
19,843
-193
| -1% | -$525 | ﹤0.01% | 2108 |
|
|
2021
Q3 | $89K | Buy |
20,036
+1,225
| +7% | +$5.44K | ﹤0.01% | 2092 |
|
|
2021
Q2 | $109K | Buy |
18,811
+7,009
| +59% | +$40.6K | ﹤0.01% | 2113 |
|
|
2021
Q1 | $83K | Sell |
11,802
-1,174
| -9% | -$8.26K | ﹤0.01% | 1561 |
|
|
2020
Q4 | $62K | Buy |
12,976
+58
| +0.4% | +$277 | ﹤0.01% | 1554 |
|
|
2020
Q3 | $75K | Buy |
12,918
+1,396
| +12% | +$8.11K | ﹤0.01% | 1433 |
|
|
2020
Q2 | $78K | Buy |
+11,522
| New | +$78K | ﹤0.01% | 1423 |
|
|
2018
Q3 | – | Sell |
-7,283
| Closed | -$331K | – | 1657 |
|
|
2018
Q2 | $331K | Buy |
7,283
+1,406
| +24% | +$63.9K | 0.01% | 1263 |
|
|
2018
Q1 | $310K | Sell |
5,877
-104
| -2% | -$5.49K | 0.01% | 1198 |
|
|
2017
Q4 | $407K | Buy |
5,981
+394
| +7% | +$26.8K | 0.01% | 1101 |
|
|
2017
Q3 | $460K | Buy |
5,587
+776
| +16% | +$63.9K | 0.01% | 986 |
|
|
2017
Q2 | $450K | Buy |
4,811
+454
| +10% | +$42.5K | 0.01% | 1004 |
|
|
2017
Q1 | $277K | Buy |
+4,357
| New | +$277K | 0.01% | 1182 |
|
|
2015
Q4 | – | Sell |
-2,915
| Closed | -$268K | – | 1280 |
|
|
2015
Q3 | $268K | Buy |
2,915
+342
| +13% | +$31.4K | 0.03% | 958 |
|
|
2015
Q2 | $226K | Buy |
+2,573
| New | +$226K | 0.02% | 1173 |
|